(Q50760089)

English

Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial--study design, baseline characteristics and effects of intervention.

scientific article published in April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial--study design, baseline characteristics and effects of intervention. (English)

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

0 references

9

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

author name string

Atsushi Araki

1

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Satoshi Iimuro

2

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Takashi Sakurai

3

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Hiroyuki Umegaki

4

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Katsuya Iijima

5

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Hiroshi Nakano

6

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Kenzo Oba

7

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Koichi Yokono

8

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Nobuhiro Yamada

10

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Junya Ako

11

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Koichi Kozaki

12

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Hisayuki Miura

13

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Atsunori Kashiwagi

14

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Ryuichi Kikkawa

15

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Yukio Yoshimura

16

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Tadasumi Nakano

17

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Yasuo Ohashi

18

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Hideki Ito

19

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Japanese Elderly Diabetes Intervention Trial Study Group

20

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

publication date

1 April 2012

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Geriatrics and Gerontology International

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

12 Suppl 1

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

7-17

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Decreased cognitive function in aging non-insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

9/Geriatric Depression Scale (GDS)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

The prevalence of multiple diabetes-related complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Diabetes and Incidence of Functional Disability in Older Women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00808.X

21 January 2018

Identifiers

10.1111/J.1447-0594.2011.00808.X

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/22435936

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50760089&oldid=937014868"